GH Research (GHRS) Profit After Tax (2020 - 2025)
GH Research's (GHRS) quarterly Profit After Tax came in at -$13.5 million in Q4 2025, down 22.21% year-on-year from -$17.3 million in Q4 2024, and up 3.86% quarter-over-quarter from -$14.0 million in Q3 2025.
GH Research (GHRS) Profit After Tax (2020 - 2025) Analysis & Trends
GH Research's Profit After Tax history runs 6 years deep, the most recent figure standing at -$13.5 million for Q4 2025.
- On a quarterly basis, Profit After Tax fell 22.21% year-over-year to -$13.5 million in Q4 2025; TTM through Dec 2025 was -$47.6 million, a 15.57% decrease from a year earlier, with the FY2025 full-year figure at -$48.3 million, down 23.86% from the prior year.
- Profit After Tax rose to -$13.5 million in Q4 2025 per GHRS's latest filing, from -$14.0 million in the prior quarter.
- Across five years, Profit After Tax topped out at $334000.0 in Q2 2022 and bottomed at -$14.0 million in Q3 2025.
- The 5-year median for Profit After Tax is -$7.9 million (2022), against an average of -$7.5 million.
- Across the five-year window, Profit After Tax plunged 19066.67% in 2021 and jumped 168.72% in 2022, its largest moves.
- Year by year, Profit After Tax stood at -$5.7 million in 2021, then slipped by 17.78% to -$6.7 million in 2022, then slumped by 32.38% to -$8.8 million in 2023, then dropped by 24.78% to -$11.0 million in 2024, then slipped by 22.21% to -$13.5 million in 2025.
- Per Business Quant, the three latest GHRS Profit After Tax figures stand at -$13.5 million (Q4 2025), -$14.0 million (Q3 2025), and -$9.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | GH Research | 1.65 Bn | 1.65 Bn | - | -13.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.48 Mn |
| Sep 30, 2025 | -14.02 Mn |
| Jun 30, 2025 | -9.29 Mn |
| Mar 31, 2025 | -10.81 Mn |
| Dec 31, 2024 | -11.03 Mn |
| Sep 30, 2024 | -12.11 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Mar 31, 2024 | -7.67 Mn |
| Dec 31, 2023 | -8.84 Mn |
| Sep 30, 2023 | -5.65 Mn |
| Jun 30, 2023 | -7.73 Mn |
| Mar 31, 2023 | -8.54 Mn |
| Dec 31, 2022 | -6.68 Mn |
| Sep 30, 2022 | -6.46 Mn |
| Jun 30, 2022 | 334,000.00 |
| Mar 31, 2022 | -8.02 Mn |
| Dec 31, 2021 | -5.67 Mn |
| Sep 30, 2021 | -2.85 Mn |
| Jun 30, 2021 | -486,000.00 |
| Mar 31, 2021 | -202,000.00 |